New Delhi [India], December 29 (ANI): Amid the rise in cases of Omicron variant of coronavirus, Central Reserve Police Force (CRPF) on Wednesday has reactivated their COVID care centre in Bawana in Delhi.
New Delhi [India], December 29 (ANI): The Drug Controller General of India (DCGI) has given approval to the Hyderbad-based pharmaceutical company Biological E to conduct phase 3 clinical trials of its COVID-19 vaccine Corbevax as a booster dose, said sources.
Raipur (Chhattisgarh) [India], December 27 (ANI): Congress MP Rahul Gandhi's "farsighted vision" brought the issue of a COVID-19 'precautionary dose' to the notice of the government, said Chhattisgarh Health Minister TS Singh Deo on Sunday.
Mumbai (Maharashtra) [India], December 26 (ANI): Maharashtra Health Minister Rajesh Tope on Saturday welcomed the Centre's decision on precautionary doses of COVID-19 vaccine for people of more than 60 years of age, frontline staff, doctors, and vaccines for children in the 15-18 age grou
Mumbai (Maharashtra) [India], December 26 (ANI): Chief Minister Uddhav Thackeray on Saturday has welcomed Prime Minister Narendra Modi's announcement to give a 'precaution dose' to doctors and front liners and vaccination for children in the 15-18 age group from January 3.
New Delhi [India], December 24 (ANI): Amid the surge in the cases of Omicron variant of COVID-19 in India, the Health Ministry on Friday said that 61 per cent of the adult population is fully vaccinated, while 89 per cent has received their first COVID-19 vaccine dose.
New Delhi [India], December 24 (ANI): The Union Health Ministry on Friday said that of the 183 Omicron positive cases reported in India, three patients have already taken three doses and 121 had a foreign travel history.
London [UK], December 23 (ANI): The University of Oxford, in collaboration with AstraZeneca, has announced interim trial data from its Phase III trials that show its candidate coronavirus vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of
Geneva [Switzerland], December 22 (ANI): Blanket booster programmes of COVID-19 vaccines are likely to prolong the pandemic, rather than ending it by diverting supply to countries that already have high levels of vaccination coverage, giving the virus more opportunity to spread and mutate, s
New Delhi [India], December 22 (ANI): Amid the emergence of the Omicron variant of coronavirus, a Delhi-based doctor said that a booster dose of COVID vaccine is a must as the protection cover of two doses declines over three to six months.
New Delhi [India], December 22 (ANI): The requirement, timing and nature of COVID vaccine booster doses will be based on scientific decisions according to Dr VK Paul, Member-Health, Niti Aayog on Wednesday.
New Delhi [India], December 20 (ANI): As India is witnessing a surge in cases of "highly transmissible" Omicron variant, Hyderabad-based Bharat Biotech has submitted the phase 3 clinical trial application to the Drugs Controller General of India (DCGI) to get approval for the booster dose